CJC-1295 No DAC and Ipamorelin is a combined peptide preparation supplied for laboratory research and analytical applications. CJC-1295 No DAC, commonly associated with Modified GRF (1-29), is studied in relation to growth hormone-releasing hormone receptor activity. Ipamorelin is a synthetic pentapeptide investigated for its activity at the growth hormone secretagogue receptor and its effects on pituitary signalling pathways.
This blend allows researchers to examine the interaction between two compounds that act through different growth hormone-related signalling pathways.
Product details:
- Product: CJC-1295 No DAC + Ipamorelin
- Alternative name: Modified GRF (1-29) + Ipamorelin
- Strength: 5mg blend
- Form: Lyophilised powder
- Appearance: White or off-white solid
- Application: Laboratory research and analysis
- Storage: Store in a cool, dry place away from heat and direct light
- Documentation: Batch-specific Certificate of Analysis supplied where available
Once prepared for laboratory analysis, the product should be stored and handled according to the supplier’s stability guidance and standard laboratory procedures.
Important: Supplied strictly for laboratory research use only. Not intended for human or veterinary consumption, diagnosis, treatment or administration. No medical or dosing advice is provided. Keep out of reach of children.
Reviews
There are no reviews yet.